Clinical Trials Browser

ALK-positive Non-small Cell Lung Cancer × lorlatinib × Clear all

NCT06361589 2024-04-12

Real World Study of Lolatinib for Advanced ALK+ NSCLC Patients

ALK-positive Non-small Cell Lung Cancer